Alpha-1 Antitrypsin Augmentation Therapy
Authors:
- 7 March 2013
- journal article
- review article
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 10 (sup1) , 64-67
Abstract
The therapy of alpha-1 antitrypsin deficiency (AATD) is an example of a medical triumph over a common hereditary disease. Based on the understanding of the pathogens of the disease as a deficiency in liver production of alpha-1 antitrypsin (AAT) resulting from inherited genetic variation in both parental AAT genes, the knowledge that A1AT functions primarily to inhibit neutrophil elastase (NE), and the observation that NE instilled into the lung of experimental animals resulted in emphysema, the concept evolved that the pulmonary manifestations of the disease could be halted by intermittent intravenous infusions of AAT purified from pooled human plasma. Following preliminary clinical studies in the academic community, and then pharmaceutical company development of large scale purification of human AAT, the FDA approved the use of weekly AAT augmentation therapy for AATD following a clinical trial which demonstrated that weekly infusions would raise to normal plasma and lung epithelial fluid levels of AAT in AAT-deficient individuals. The therapy is now used worldwide to treat AATD, the only pulmonary genetic disease with effective therapy for all affected individuals.Keywords
This publication has 22 references indexed in Scilit:
- Manipulating the Immune System with Immune GlobulinNew England Journal of Medicine, 1992
- ABC of transfusion. Plasma, plasma products, and indications for their use.BMJ, 1990
- Alpha-1-Antitrypsin Deficiency: High Prevalence in the St. Louis Area Determined by Direct Population ScreeningAmerican Review of Respiratory Disease, 1989
- SMOKING, LUNG FUNCTION, AND α1-ANTITRYPSIN DEFICIENCYThe Lancet, 1985
- Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.Journal of Clinical Investigation, 1981
- Replacement Therapy in Hereditary AngioedemaNew England Journal of Medicine, 1980
- Experimental EmphysemaArchives of Environmental Health: An International Journal, 1965
- The Electrophoretic α; 1 -Globulin Pattern of Serum in α; 1 -Antitrypsin DeficiencyScandinavian Journal of Clinical and Laboratory Investigation, 1963
- CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA 12Journal of Clinical Investigation, 1944
- On the Protective Substances of Immune SeraEpidemiology and Infection, 1902